This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Loop Capital analyst Mark Schappel initiated coverage on Palantir Technologies Inc. PLTR with a Buy rating and announced a price target of $141. Palantir shares closed at $112.06 on Wednesday. See how other analysts view this stock.
• Canaccord Genuity analyst Whitney Ijem initiated coverage on Palvella Therapeutics, Inc. PVLA with a Buy rating and announced a price target of $39. Palvella Therapeutics shares closed at $20.97 on Wednesday. See how other analysts view this stock.
• Citigroup analyst Yigal Nochomovitz initiated coverage on Candel Therapeutics, Inc. CADL with a Buy rating and announced a price target of $25. Candel Therapeutics shares closed at $10.47 on Wednesday. See how other analysts view this stock.
• Baird analyst Jeff Johnson initiated coverage on Beta Bionics, Inc. BBNX with a Neutral rating and announced a price target of $20. Beta Bionics shares closed at $21.81 on Wednesday. See how other analysts view this stock.
• B. Riley Securities analyst Kyle Bauser initiated coverage on Electromed, Inc. ELMD with a Buy rating and announced a price target of $38. Electromed shares closed at $28.54 on Wednesday. See how other analysts view this stock.

Considering buying PLTR stock? Here’s what analysts think:

Read This Next:

• Walmart, Dropbox And 3 Stocks To Watch Heading Into Thursday